Nektar Therapeutics: Form 8-K, filed May 7, 2026
Filed with the SEC on May 7, 2026 and accepted by EDGAR at May 7, 2026, 20:30 ET.
Items reported
- Item 2.02 Results of operations
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-26-053369. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.